Skip to main content

Table 1 Demographic and clinical characteristics of the subjects enrolled in the study.

From: IP-10 detection in urine is associated with lung diseases

  Total Pulmonary TB Lung disease other than TB Healthy subjects Pulmonary TB after 2 mo AFB smear reversion Pulmonary TB Cured p value
  N (%)
138 (100.0)
N (%)
58 (42.1)
N (%)
28 (20.3)
N (%)
34 (24.6)
N (%)
9 (6.5)
N (%)
9 (6.5)
 
Mean Age (SD) 35.87 (12.06) 32.43 (10.63) 41.89 (14.54) 38.88 (8.06) 31.60 (6.92) 32.11 (19.18) =0.003
Female gender 48 (34.8) 18 (31.0) 8 (28.6) 16 (47.1) 1 (11.1) 5 (55.6) =0.137
Origin        < 0.0001
Eastern Europe 46 (33.3) 31 (53.4) 5 (17.9) - 4 (44.4) 6 (66.7)  
Western Europe 49 (35.5) 10 (17.2) 4 (14.3) 32 (94.1) 1 (11.1) 2 (22.2)  
Africa 14 (101) 4 (6.9) 10 (35.7) - - -  
South America 7 (5.1) 2 (3.4) 1 (3.6) 2 (5.9) 1 (11.1) 1 (11.1)  
Asia 22 (15.9) 11 (19.0) 8 (28.6) - 3 (33.3) -  
BCG        < 0.0001
BCG-positive 61 (44.2) 39 (67.2) 14 (50.0) 6 (17.6) 1 (11.1) 2 (22.2)  
BCG-negative 57 (41.3) 10 (17.2) 4 (14.3) 28 (82.4) 8 (88.9) 7 (77.8)  
BCG-unknown 19 (15.8) 9 (15.5) 10 (35.7) -    
Pulmonary TB
microbiological diagnosis
- 48 (82.8) - - 9 (100.0) 9 (100.0)  
Pulmonary TB
clinical diagnosis
- 10 (17.2) - -    
Pulmonary diseases
other than TB
       
Pneumonia - - 16 (57.1) -    
Cancer - - 2 (7.1) -    
Bronchitis - - 3 (10.7) -    
COPD* - - 6 (21.4) -    
Pleural effusion
not TB related
- - 1 (3.6) -    
Mean Bacteriuria
(SD)
1770
(1632)
1911
(1988)
1944
(1446)
1346
(787)
685
(830)
2347
(1817)
=0.352
HIV status        =0.118
HIV-positive 4 (2.9) 1 (1.7) 2 (7.1) - 1 (11.1) -  
HIV-negative 126 (91.3) 55 (94.8) 23 (82.1) 34 (100.0) 5 (55.6) 9 (100.0)  
HIV-unknown 8 (5.8) 2 (3.4) 3 (10.7) - 3 (33.3) -  
  1. TB: tuberculosis; HIV: human immunodeficiency virus; SD: standard deviation; BCG: Bacillus Calmètte et Guerin; COPD: chronic obstructive pulmonary diseases.